Current Issues in Psychopharmacology

Parkinson’s Disease (PD) affects one out of every 200 people in the United States over the age of 50, with 10% of the overall diagnosed younger than 50 years of age, for a combined total U.S. prevalence of 66 to 258/100,000 (Wickens, 2005; Berger, Dodel, & Oertel, 2001). The clinical presentation of PD usually includes... Continue Reading →

Powered by WordPress.com.

Up ↑